Genetic diagnostic profiling in axial spondyloarthritis: a real world study.
Gethin Thomas(The University of Queensland), Matthew A. Brown(Translational Research Institute), Martín Rudwaleit(Bielefeld University), Rafael Valle‐Oñate(Hospital Militar Central), Nurullah Akkoç(Izmir Institute of Technology), Paul Leo(The University of Queensland), James Cheng‐Chung Wei(China Medical University), Salih Özgöçmen(Tokat Gaziosmanpaşa Üniversitesi), Adrián Cortés(Institut thématique Génétique, génomique et bioinformatique), Dana Willner(The University of Queensland), Jürgen Braun(Center for HIV and Hepatogastroenterology), Walter P. Maksymowych(University of Alberta), Joachim Sieper(Charité - Universitätsmedizin Berlin), Euthalia Roussou(Barking, Havering And Redbridge University Hospitals NHS Trust), Ran Duan(Central South University), Désirée van der Heijde(Leiden University Medical Center), Chung Tei Chou(National Yang Ming Chiao Tung University), Philip C. Robinson(The University of Queensland)
PubMed
June 13, 2017
Cited by 26
Related Papers
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.5k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k